UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000059099
Receipt number R000067567
Scientific Title Behavioral and neural associations between olfactory, motor, and cognitive impairments in patients receiving rehabilitation treatments
Date of disclosure of the study information 2025/09/16
Last modified on 2025/09/16 17:36:56

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Behavioral and neural associations between olfactory, motor, and cognitive impairments in patients receiving rehabilitation treatments

Acronym

Behavioral and neural associations between olfactory, motor, and cognitive impairments in patients receiving rehabilitation treatments

Scientific Title

Behavioral and neural associations between olfactory, motor, and cognitive impairments in patients receiving rehabilitation treatments

Scientific Title:Acronym

Behavioral and neural associations between olfactory, motor, and cognitive impairments in patients receiving rehabilitation treatments

Region

Japan


Condition

Condition

patients receiving rehabilitation treatments

Classification by specialty

Rehabilitation medicine Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This research project has two objectives. One objective is to investigate (1) the prevalence of olfactory impairments in patients receiving rehabilitation treatments, (2) associations between olfactory impairments and cognitive/motor impairments and outcomes, and (3) their underlying neural mechanisms. The other objective is to elucidate general/inherent associations between olfactory functions and cognitive/motor functions, in particular those relevant to rehabilitation such as memory, learning, and emotion, through behavioral experiments.

Basic objectives2

Others

Basic objectives -Others

associations between olfactory, motor, and cognitive functions and impairments

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

clinical assessments (such as FIM, SIAS, MMSE, and MoCA-J), olfactory abilities, psychological and physiological responses to olfactory stimuli

Key secondary outcomes

demographics, behavioral (non-clinical) assessments of motor and cognitive functions, brain images


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Behavior,custom Other

Interventions/Control_1

behavioral assessments on olfactory, motor, and/or cognitive functions, brain imaging, regular clinical physical/functional evaluations

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

patients
a) inpatients/outpatients of the rehabilitation department at Fujita Health University Hospital
b) being able to maintain sitting posture on a chair with a backrest
c) a current diagnosis or a history of an olfactory, motor or cognitive impairment
d) an adult (18 years or older) who can provide informed consent by oneself.

healthy individuals
a) no history of brain, neuromuscular, or psychological diseases and no history of epileptic seizure
b) an adult (18 years or older) who can provide informed consent by oneself.

Key exclusion criteria

patients
A) unable to maintain sitting posture on a chair with a backrest
B) unable to follow instructions by physicians, therapists, or other health practitioners
C) a history of epileptic seizure
D) currently pregnant
E1) (only for those who receive MRI scanning) having in the body a pacemaker, aneurysm clip, pump, electrodes, or any other metal object that may be incompatible with MRI.
E2) (only for those who receive MRI scanning) unable to maintain supine posture during MRI scanning

healthy individuals
A) a history of a brain, neuromuscular, or psychological disease or a history of epileptic seizure
B) currently pregnant
C1) (only for those who receive MRI scanning) having in the body a pacemaker, aneurysm clip, pump, electrodes, or any other metal object that may be incompatible with MRI.
C2) (only for those who receive MRI scanning) having non-removable makeup/tattoo/accessory that either (a) is too close to the head/neck, (b) contains MRI-incompatible metals, (c) is so wide/large that it may compromise safety during MRI scanning

Target sample size

600


Research contact person

Name of lead principal investigator

1st name Yohei
Middle name
Last name Otaka

Organization

Fujita Health University School of Medicine

Division name

Department of Rehabilitation Medicine

Zip code

470-1192

Address

1-98, Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, Japan

TEL

0562-93-2167

Email

rehabmed@fujita-hu.ac.jp


Public contact

Name of contact person

1st name Yohei
Middle name
Last name Otaka

Organization

Fujita Health University School of Medicine

Division name

Department of Rehabilitation Medicine

Zip code

470-1192

Address

1-98, Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, Japan

TEL

0562-93-2167

Homepage URL


Email

otaka119@mac.com


Sponsor or person

Institute

Fujita Health University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Review Committee of Fujita Health University

Address

1-98, Dengakugakubo Kutsukake-cho, Toyoake-shi Aichi 470-1192, Japan

Tel

0562-93-2865

Email

f-irb@fujita-hu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

藤田医科大学病院(愛知県)


Other administrative information

Date of disclosure of the study information

2025 Year 09 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2025 Year 07 Month 31 Day

Date of IRB

2025 Year 07 Month 31 Day

Anticipated trial start date

2025 Year 09 Month 22 Day

Last follow-up date

2029 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 09 Month 16 Day

Last modified on

2025 Year 09 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067567